INVESTIGADORES
BRUNO Mariela AnahÍ
congresos y reuniones científicas
Título:
Enzymatic hydrolysis treatment to reduce Beta-lactoglobulin antigenicity. Assessment of the method performance.
Autor/es:
AMBROSI, VANINA; GONZÁLEZ, CLAUDIA; BRUNO MARIELA A.; POLENTA, GUSTAVO
Lugar:
Rotterdam
Reunión:
Conferencia; 7th International Whey Conference 2014; 2014
Institución organizadora:
NIZO food research and EWPA
Resumen:
Cow Milk Allergy is the most common food allergy in
infants. Children suffering from this condition are recommended to consume
replacement products, known as hypoallergenic infant formulas (HIF). These HIF
are usually made of extensively hydrolyzed proteins. Regarding the quality
standard to be attained, Pediatrics Associations agree that clinically
hypoallergenic formulas must not cause allergic symptoms when fed to 90% of
allergic infants.
The assessment of this requirement constitutes a challenge from the analytical
point of view. In addition, studies aiming at developing processes able to reduce
the allergenicity of proteins are rather scarce. We have recently developed a
competitive ELISA which, contrarily to commercial methods, was adapted to
measuring the remaining antigenicity of whey proteins without the need of
diluting samples at high levels. In the present work, we tested the performance
of the method by monitoring the remaining antigenicity of whey proteins
subjected hydrolytic treatments. For monitoring purposes, we chose
¥â-lactoglobulin (BLG) as the marker protein, considering that it constitutes
the main whey allergen. With that purpose, 1% w/v solutions of 80% w/w whey
protein concentrate (WPC-80-1) were processed by enzymatic hydrolysis with 3 commercial
proteases: bromelain, papain and trypsin (45¨¬C, E:S ratio 1:10, t=0, 30, 120
min). Untreated WPC-80-1 was used as a control. The method proved suitable to
quantify the remaining antigenicity of BLG subjected to the different
treatments. Regarding the efficiency of the treatments, hydrolysis with papain (120
min) was the most effective to reduce BLG antigenicity, rendering 89% of reduction.
Although further studies should be conducted to validate the methodology,
preliminary results are highly promising. Thus, the monitoring method can be
regarded as a powerful tool to develop novel processes based on enzymatic
hydrolysis. In addition, its application in quality control activities can lead
to the production of high quality analytically certified HIF.